Remission in Subjects With Crohn's Disease, Open Label Extension
Public ClinicalTrials.gov record NCT01070303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Maintenance of Clinical Remission in Subjects With Crohn's Disease, Open Label Extension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objectives were: (1) To demonstrate the efficacy of adalimumab in the long-term maintenance of clinical remission in participants with Crohn's disease; and (2) To delineate the long-term safety of adalimumab when administered to participants with Crohn's disease.
Study identification
- NCT ID
- NCT01070303
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 177 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2002 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Apr 11, 2011
2002 – 2008
United States locations
- U.S. sites
- 43
- U.S. states
- 21
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gastroenterology Associates of the East Bay | Berkeley | California | 94705 | — |
| Long Beach Gastroenterology Assoc. | Long Beach | California | 90806 | — |
| Sharp Rees-Stealy Medical Group | San Diego | California | 92123 | — |
| Gastroenterology Assoc. of Fairfield Co. | Bridgeport | Connecticut | 06606 | — |
| Cleveland Clinic Florida | Weston | Florida | 33331 | — |
| Wake Research Associates | Weston | Florida | 33331 | — |
| Shafran Gastroenterology Center | Winter Park | Florida | 32789 | — |
| Atlanta Gastroenterology Assoc. | Atlanta | Georgia | 30342 | — |
| Southeastern Digestive & Liver Disease | Savannah | Georgia | 31404 | — |
| Northwest Gastroenterologists, S.C. | Arlington Heights | Illinois | 60005 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Drug Research Services, Inc. | Metairie | Louisiana | 70001 | — |
| LSU School of Medicine | New Orleans | Louisiana | 70115 | — |
| Digestive Disorders Associates | Annapolis | Maryland | 21401 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Clinical Pharmacology Study Group | Worchester | Massachusetts | 01610 | — |
| Mayo Clinic and Mayo Foundation | Rochester | Minnesota | 55905 | — |
| Gastroenterology and Hepatology | Kansas City | Missouri | 64131 | — |
| Glenn Gordon, MD | Mexico | Missouri | 65265 | — |
| Deaconess Billings Clinic Research Division | Billings | Montana | 59101 | — |
| Gastroenterology Specialties, P.C. | Lincoln | Nebraska | 68503 | — |
| Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| NY Center for Clinical Research | Lake Success | New York | 11042 | — |
| New York Presbyterian Hospital | New York | New York | 10021 | — |
| Daniel Present | New York | New York | 10029 | — |
| Rochester Institute for Digestive Diseases | Rochester | New York | 14607 | — |
| UNC School of Medicine | Chapel Hill | North Carolina | 27599 | — |
| Charlotte Gastroenterology and Hepatology | Charlotte | North Carolina | 28207 | — |
| Carolina Research Associates | Charlotte | North Carolina | 28262 | — |
| Digestive Health Specialists | Winston-Salem | North Carolina | 27103 | — |
| Consultants for Clinical Research | Cincinnati | Ohio | 45219 | — |
| Oklahoma Foundation for Digestive Disease | Oklahoma City | Oklahoma | 73104 | — |
| Research Solutions | Tulsa | Oklahoma | 74104 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Peter Molloy, MD | Pittsburgh | Pennsylvania | 15224 | — |
| Diseases of the Digestive System | Chattanooga | Tennessee | 37421 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| Charlottesville Medical Research | Charlottesville | Virginia | 22902 | — |
| Northwest Gastroenterology | Bellevue | Washington | 98004 | — |
| Inland Empire Gastroenterology | Spokane | Washington | 99204 | — |
| Tacoma Digestive Disease Center | Tacoma | Washington | 98405 | — |
| Wisconsin Center for Advanced Research | Milwaukee | Wisconsin | 53207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01070303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 11, 2011 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01070303 live on ClinicalTrials.gov.